Medytox to supply $73 mn botulinum toxin to Brazilian firm

Medytox to supply $73 mn botulinum toxin to Brazilian firm

South Korea's biopharmaceutical firm Medytox Inc. announced on Tuesday that it signed a contract with Brazilian pharmaceutical company Blau Farmaceu...

Medytox establishes US subsidiary Luvantas

Medytox establishes US subsidiary Luvantas

South Korean pharmaceutical company Medytox Inc. announced on Wednesday that its establishment of the US subsidiary Luvantas.The goal is the global ...

Medytox to enter China’s botulinum toxin market with Newlux

Medytox to enter China’s botulinum toxin market with Newlux

South Korean pharmaceutical company Medytox Inc. on Tuesday announced its plan to enter the Chinese market for botulinum toxins (BTX) with its cut...

Dubai delegation conducts due diligence on Medytox's plant in Korea

Dubai delegation conducts due diligence on Medytox's plant in Korea

South Korea's biopharmaceutical firm Medytox Inc. said on Monday that a high-level delegation led by Dubai Science Park (DSP) under Dubai's state-ow...

US calls on 2 S.Korean pharmaceutical companies for swift end to legal battle

US calls on 2 S.Korean pharmaceutical companies for swift end to legal battle

Following its lawsuit against Daewoong Pharmaceutical, South Korea's Medytox Inc. is waging an all-out legal war against domestic counterpart Hugel ...

Korean court rules Daewoong poached Medytox’s botox strain

Korean court rules Daewoong poached Medytox’s botox strain

A South Korean court on Friday ruled in favor of Medytox Inc. in a civil lawsuit against its crosstown rival Daewoong Pharmaceutical Co. over the so...

Medytox to sell off 2.2 mn shares of Daewoong's American partner Evolus

Medytox to sell off 2.2 mn shares of Daewoong's American partner Evolus

Medytox Inc. said in a regulatory filing on Wednesday that it is selling off approximately 2.19 million shares of Evolus, Daewoong Pharmaceutical's ...

Medytox to build plant for finished toxin products in Dubai

Medytox  to build plant for finished toxin products in Dubai

South Korea's biopharmaceutical company Medytox Inc. will build a plant for finished products containing botulinum toxin in the United Arab Emirates...

Medytox-Hugel dispute over botox strain intensifies with ITC probe

Medytox-Hugel dispute over botox strain intensifies with ITC probe

A legal dispute over a botox strain between South Korean pharmaceutical company Medytox Inc. and its crosstown rival Hugel Inc. has intensified with...

Medytox files complaint with ITC against Hugel over botox strain

Medytox files complaint with ITC against Hugel over botox strain

South Korean pharmaceutical company Medytox Inc. has filed a complaint with the International Trade Commission (ITC) against Hugel Inc., alleging th...

Medytox’s US business outlook dim as contract with AbbVie ends

Medytox’s US business outlook dim as contract with AbbVie ends

South Korea’s pharmaceutical company Medytox Inc. has ended a botulinum toxin-related technology transfer contract with AbbVie, clouding its b...

Kakao Pay backs out of acquisition deal for SSG Pay, Smile Pay Hanwha in talks to buy five-star hotel Paraspara Seoul Kia's Lego-like PV5 with 16 variants to hit market in July Stray Kids make K-pop history with landmark stadium show in Germany S.Korea’s most prominent business leader returns with all charges cleared